BioCentury
ARTICLE | Editor's Commentary

Keep calm and carry on biotech: A Perspective

U.K. biotech still bubbling with enthusiasm, even as pharma pressure casts a long shadow: takeaways from BioCentury Grand Rounds — Europe

September 27, 2025 12:04 AM UTC

Perhaps the most British thing about U.K. biotech is its ability to keep marching on, head held high, even while the body blows keep coming and doomsayers ring death knells. The concerns about pharmas pulling out of the U.K. are real and mounting, but the optimism and willingness of innovators and investors to get on with the business of biotech may be what gets this sector through some tough times, and ultimately lets it thrive.

U.K. biotech is perfecting the art of seeing the landmines, while keeping the horizon in clear view...